Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Toon Overbeeke.

Executive Summary

Dutch-based Vitestro will soon enter pivotal trials with its autonomous blood-sampling device, which it hopes to market in 2024, pending regulatory approval. See what Vitestro’s CEO, Toon Overbeeke, said about one of the challenges in the ongoing development of the phlebotomist robot here.

“You really need submillimeter precision in order to make sure that the needle is really in the middle of the vein.” – Toon Overbeeke, CEO, Vitestro

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT145474

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel